Emergent Biosolutions Inc. Stock
Emergent Biosolutions Inc. took a tumble today and lost -€0.204 (-4.490%).
Based on 2 Buy predictions and 3 Sell predictions the sentiment towards Emergent Biosolutions Inc. is rather balanced.
With a target price of 4 € there is a slightly negative potential of -8.65% for Emergent Biosolutions Inc. compared to the current price of 4.38 €.
Our community identified positive and negative aspects for Emergent Biosolutions Inc. stock for the coming years. 1 users see the criterium "Company culture" as a plus for the Emergent Biosolutions Inc. stock. On the other hand our users think that "Worthwhile Investment for the next years" could be a problem in the future.
Pros and Cons of Emergent Biosolutions Inc. in the next few years
Pros
?
B****
?
C******** o* t** e**********
?
W********* I********* f** t** n*** y****
Cons
?
G***** c******* t* c**********
?
M***** P*******
?
S********** s********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Emergent Biosolutions Inc. vs. its peers
Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
---|---|---|---|---|---|---|---|
Emergent Biosolutions Inc. | -4.490% | -14.305% | 115.396% | -44.145% | 96.544% | -90.671% | -88.762% |
Ironwood Pharmaceuticals | -7.500% | -4.310% | -25.503% | -44.221% | -45.588% | -45.050% | - |
Novocure Ltd | 4.840% | 5.435% | 89.436% | -71.271% | 49.492% | -85.644% | - |
Iovance Biotherapeutics Inc. | -2.500% | -2.040% | -15.627% | 22.927% | 18.110% | -36.836% | - |
Comments
Emergent BioSolutions Inc. (NYSE: EBS) had its "buy" rating re-affirmed by analysts at Benchmark Co.. They now have a $5.00 price target on the stock.
Show more
Ratings data for EBS provided by MarketBeat
Emergent BioSolutions Inc. (NYSE: EBS) was upgraded by analysts at Benchmark Co. from a "hold" rating to a "buy" rating. They now have a $5.00 price target on the stock.
Show more
Ratings data for EBS provided by MarketBeat
Emergent BioSolutions Inc. (NYSE: EBS) had its "underweight" rating re-affirmed by analysts at JPMorgan Chase & Co..
Show more
Ratings data for EBS provided by MarketBeat